3.96
price down icon2.22%   -0.09
pre-market  Pre-mercato:  3.95   -0.010   -0.25%
loading

Altimmune Inc Borsa (ALT) Ultime notizie

pulisher
Nov 03, 2025

Will Altimmune Inc. stock reach all time highs in 2025Market Performance Recap & Safe Entry Momentum Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Technical analysis overview for Altimmune Inc. stockJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Altimmune Inc. stock is a value investor pickQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune completes enrollment for alcohol use disorder trial - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune (ALT) Completes Enrollment for Phase 2 AUD Trial - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Does Altimmune Inc. show high probability of reboundJuly 2025 Outlook & Fast Entry and Exit Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune Completes Patient Enrollment Ahead of Schedule in Phase 2 Clinical Trial for Pemvidutide in Alcohol Use Disorder - Quiver Quantitative

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Should you wait for a breakout in Altimmune Inc.Stop Loss & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune Inc. stock chart pattern explainedQuarterly Trade Review & Consistent Income Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How strong is Altimmune Inc. stock revenue growthGlobal Markets & Weekly Momentum Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using AI based signals to follow Altimmune Inc.July 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

How Altimmune Inc. stock performs during Fed tightening cyclesMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How to use Fibonacci retracement on Altimmune Inc.Quarterly Trade Report & High Accuracy Swing Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Altimmune (ALT) to Release Quarterly Earnings on Thursday - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Tools to monitor Altimmune Inc. recovery probability2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Automated trading signals detected on Altimmune Inc.2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Moody Aldrich Partners LLC Invests $610,000 in Altimmune, Inc. $ALT - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Can technical indicators confirm Altimmune Inc.’s reversalMarket Risk Report & Weekly High Return Stock Opportunities - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.

Oct 31, 2025
pulisher
Oct 31, 2025

Forecasting Altimmune Inc. price range with options dataFed Meeting & Risk Managed Investment Entry Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to forecast Altimmune Inc. trends using time seriesWatch List & Free Risk Controlled Daily Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What technical charts say about Altimmune Inc. stockQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What MACD and RSI say about Altimmune Inc.2025 Market Trends & Detailed Earnings Play Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using fundamentals and technicals on Altimmune Inc.Risk Management & Community Consensus Stock Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can momentum traders help lift Altimmune Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha

Oct 30, 2025
pulisher
Oct 30, 2025

Altimmune (Nasdaq: ALT) schedules Nov 6 results call at 8:30 a.m. ET with business update - Stock Titan

Oct 30, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):